Anti-Rabies Serum Market Size Projected To Increase From $1.58 Billion To $1.94 Billion During The Forecast Period
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Anti-Rabies Serum Market Expected To Reach $1.94 Billion By 2030 At 5.3% CAGR
The market for anti-rabies serum has experienced robust expansion in recent times. Projected to rise from $1.5 billion in 2025 to $1.58 billion in 2026, it reflects a compound annual growth rate (CAGR) of 5.6%. This historical growth has been driven by a higher number of rabies exposure incidents, broader implementation of emergency treatment protocols in hospitals, the accessibility of immunoglobulins derived from equine sources, government-backed initiatives for rabies control, and increased public understanding of post-exposure prophylaxis.
The market for anti-rabies serum is anticipated to experience robust expansion over the coming years. Projections indicate it will reach $1.95 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.3%. This upward trajectory during the forecast period is driven by factors such as the growing utilization of human anti-rabies immunoglobulin, the broadening of rabies prevention efforts in developing regions, heightened investments in biologics manufacturing, an increased emphasis on safer serum options, and the reinforcement of public health vaccination frameworks. Key developments shaping this period include a greater uptake of human-derived immunoglobulins, a shift toward prefilled syringe formats, the optimization of cold-chain logistics for serum distribution, a heightened focus on high-purity antibody formulations, and the enhanced standardization of post-exposure prophylaxis procedures.
Download A Free Sample Report For Comprehensive Market Insights:
Anti-Rabies Serum Market Growth Factors Supporting Long-Term Expansion
The growing frequency of dog bites is anticipated to boost the anti-rabies serum market in the coming period. Dog bites are defined as wounds inflicted when a dog bites or scratches a person, with severity ranging from mild to serious. Such incidents can result in infections, deep wounds, and occasionally the transmission of diseases like rabies. Proper prevention and rapid medical intervention are essential for reducing and controlling the hazards associated with dog bites. This increase in dog bite occurrences is driven by factors including growing urbanization, which leads to more frequent human-dog encounters, a larger number of stray or inadequately trained dogs, and limited public knowledge regarding canine behavior and bite avoidance. Consequently, the rising rate of dog bites has heightened the demand for anti-rabies serum, since its prompt administration is vital for preventing rabies in individuals exposed to possibly infected animals. For example, in 2023, the American Veterinary Medical Association, a US-based nonprofit, reported that the average cost for dog bite insurance claims that year was $58,545, with insurers paying out $1.12 billion in liability claims for dog bites and related injuries. Dog bite claims rose by almost 10% in 2023. Hence, the increasing prevalence of dog bites is propelling expansion in the anti-rabies serum market.
Anti-Rabies Serum Market Segment Landscape: Which Areas Lead Market Development?
The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals
Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
Anti-Rabies Serum Market Industry Trends Shaping Future Revenue Growth
Leading players within the anti-rabies serum sector are increasingly turning to strategic alliances as a key method for advancing product innovation and broadening their footprint in the marketplace. Such strategic partnerships involve companies harnessing each other’s capabilities and assets to create shared advantages and drive mutual growth. A notable example occurred in July 2023, when Kedrion S.p.A., a biopharmaceutical firm based in the United States, joined forces with Kamada, an Israeli biopharmaceutical company, to bring KEDRAB (Rabies Immune Globulin [Human]) to the U.S. market. This joint venture has played a crucial role in both the co-development and licensing of the product across the country, while simultaneously boosting awareness about the disease. Through their collaborative initiatives, this alliance has been instrumental in safeguarding individuals who come into contact with rabid animal bites from severe and potentially fatal health outcomes.
Anti-Rabies Serum Market Industry Leaders And Market Competition
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals
Access The Complete Anti-Rabies Serum Market Report:
Anti-Rabies Serum Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the anti-rabies serum market in 2025. The regions covered in the anti-rabies serum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
